Pneumococcal community-acquired pneumonia in hospitalized adults in México 2018–2021: serotype distribution and clinical characteristics
Open Access
- 9 July 2026
- journal article
- research article
- Published by Frontiers Media SA in Frontiers in Public Health
- Vol. 14, 1803418
Abstract
Background: Community-acquired pneumonia (CAP) in adults represents a significant burden on the healthcare system in México, particularly among high-risk groups. Materials and methods: Adults hospitalized with chest X-ray-confirmed CAP (2018–2021) were prospectively enrolled across four cities in México (Mexico City, Durango, Mérida, and Tijuana). Urine samples were screened for Streptococcus pneumoniae ( S. pneumoniae ) using the BinaxNOW ® test and serotype-specific urine antigen detection (ssUAD) assays targeting 24 serotypes, and blood was obtained for pneumococcal culture. Results: Of the 1,275 patients screened for CAP, 389 had clinically or radiologically confirmed CAP (65.3% male; median age, 60 years; 39.3% aged ≥65 years). Pneumococcal CAP (pCAP) was identified in 12.1% of patients (47/389; 95% CI: 9.01–15.74). Based on CRB-65 scores, pCAP was more frequent among high-risk CAP patients (25.5%, 12/47) than among low- or moderate-risk CAP patients (10.2%, 35/342). Nevertheless, the 30-day mortality rate was 34.0% among pCAP patients versus 29.5% among S. pneumoniae -negative CAP patients. The most prevalent serotypes were 3 (13.0%), 6A (8.7%), and 19A (8.7%), and PCV20 would have covered 54.3% (25/46) of pCAP serotypes identified in this study. Conclusion: During the study period, CAP was associated with a substantial mortality burden among hospitalized adult patients in México, with pCAP more frequent among high-risk patients. These findings underscore the needs for enhanced diagnostic approaches and risk group-targeted adult pneumococcal vaccination programs.Keywords
Funding Information
- Pfizer
This publication has 39 references indexed in Scilit:
- Pneumococcal meningitis in Mexico. Serotype distribution and antimicrobial resistance before and after the introduction of pneumococcal conjugate vaccines in pediatric patients. Results from the GIVEBPVac groupJournal of Infection and Public Health, 2025
- Health-care policies during the COVID-19 pandemic in Mexico: A continuous case of heterogeneous, reactive, and unequal responseHealth Policy OPEN, 2023
- EE188 Health and Economic Impact of 23-Valent Pneumococcal Polysaccharide Vaccine in the Older Adult Immunization Program in MexicoValue in Health, 2022
- Leading causes of excess mortality in Mexico during the COVID-19 pandemic 2020–2021: A death certificates study in a middle-income countryThe Lancet Regional Health - Americas, 2022
- Clinical and microbiological characteristics of community-acquired pneumonia associated with Streptococcus pneumoniae in adult patients in MexicoRevista Argentina de Microbiologia, 2019
- Smoking and alcohol abuse are the most preventable risk factors for invasive pneumonia and other pneumococcal infectionsInternational Journal of Infectious Diseases, 2014
- Morbidity and mortality of pneumonia in adults in six Latin American countriesInternational Journal of Infectious Diseases, 2013
- Prevalence of Pneumococcal Disease, Serotype Distribution, and Antimicrobial Susceptibility in Mexican Children Younger than 5 Years of AgeArchives of Medical Research, 2013
- Clinical and economic burden of pneumonia among adults in Latin AmericaInternational Journal of Infectious Diseases, 2010
- BACTERIAL ADHERENCE IN SMOKERS AND NON-SMOKERSPharmacological Research, 1997